OTCPicks.com

FEATURED COMPANY

ANGSTROM MICROSYSTEMS CORPORATION (OTCBB: AGMS)

Detailed Quote: www.otcpicks.com/quotes/AGMS.php

Company Profile:
http://www.otcpicks.com/angstrom-microsystems/angstrom-microsystems.htm

Angstrom Microsystems is one of the top Green computing companies, providing technology solutions ranging from liquid-cooled blades to acceleration software in order to help reduce the power requirements of datacenters. Its customers include Rhythm & Hues, Fox Films, Tippett Studios and the National Institutes of Health. Angstrom has earned a reputation for quality, service, and engineering innovation in the AMD Opteron processor-based system market. See Angstrom Microsystems in the end credits of Blue Sky Studios' "Ice Age: The Meltdown."

AGMS News:

September 3 - Angstrom Microsystems Acceleration Software Uses Gaming Technology to Save Data Centers Energy

Faster Servers Mean Fewer Servers Needed, Saving Overall Power Usage in the $15 Billion High Performance Computing (HPC) Market

Angstrom Microsystems Corp. (OTCBB: AGMS) is a market leader in "Green Computing" solutions. Angstrom's Xfactor Plus(TM) acceleration software saves energy within data centers by reducing the number of machines needed to run certain computation-intensive calculations for various types of applications, hence saving air conditioning and electricity in the data center. A report by the EPA dated August 2007 indicates the severe nature of the power and air-conditioning problem befalling data centers around the U.S.

Typically used by video game enthusiasts, high-end graphics cards (Graphic Processing Units - GPUs) drive Angstrom's software, providing plug-and-play ultra-fast solutions for the HPC market. As commercial off-the-shelf (COTS) components, GPUs are critical to Angstrom's success by driving down hardware costs for comparable computations, while providing a path to compatibility with existing customer software.

Xfactor Plus provides speed increases between 10x and 100x depending on the application or library being accelerated and is fully compatible with existing software. An Increase in performance per computer often leads to a reduction in their numbers, saving data center resources that would have otherwise been spent on inefficient computing.

Angstrom's Xfactor Plus software acceleration solutions are geared towards a variety of vertical market segments including high performance computing, life sciences, movie special effects and animation rendering, oil and gas applications, design and automation, broadcast applications and Internet multi-media.

"Angstrom was recently first-to-market with the popular FFTW (Fast Fourier Transform) compatible library solution based on the core Xfactor Plus technology," said Lalit Jain, CEO of Angstrom Microsystems. Mr. Jain continues, "Our Xfactor Plus 'FFTW' library has been very successful, and we are actively working on many other software acceleration solutions to address a variety of other high-end vertical market server applications."

Xfactor Plus is sold as a stand-alone package that can be installed on existing Linux-based computers and as a turnkey solution installed on Angstrom hardware.

FEATURED COMPANY

COPPER KING MINING CORPORATION (OTC: CPRK)

Detailed Quote: www.otcpicks.com/quotes/CPRK.php

Company Profile:
www.otcpicks.com/copper-king-mining/copper-king-mining.htm

Copper King Mining Corporation currently owns approximately 1200 acres in the Drum Mountains of Utah, which are patent deeded mining claims which contain gold, silver and copper. The company recently added to its holdings by filing six more claims on land which was inside their holdings, but not patent deeded. Contiguous to that acreage is approximately 1100 acres of claims filed by Western Utah Copper Company. As the companies explored the concept of a joint venture on the Drum Mountain properties, it was decided that a very viable consideration was to join the total assets of both companies.

CPRK News:

September 3 - Copper King Mining Corporation Announces Bridge Funding

Copper King Mining Corporation (OTC: CPRK), an ore mining, processing, and exploration company located in Southern Utah, announced that it closed on bridge funding with a third party lender.

Copper King today announced that it closed a private transaction on Friday, August 29, 2008, for bridge funding that is associated with its anticipated permanent bond financing. The company affirmed that the bridge funding was completed by a third party investor in a related industry; that the terms of the financing are favorable to the company; and that no equity was involved in the transaction.

The company anticipates using the bridge funding to complete construction of its state-of-the-art Flotation Mill near Milford, Utah.

FEATURED COMPANY

GENERAL AUTOMOTIVE COMPANY (OTCBB: GNAU)

Detailed Quote: http://www.otcpicks.com/quotes/GNAU.php

Company Profile:
http://www.otcpicks.com/general-automotive/general-automotive-2.htm

General Automotive Company ("GAC") is a provider of original equipment and aftermarket automotive parts, mobile electronics, and related automotive products at multiple levels of distribution throughout the United States and internationally. Through its two wholly owned subsidiaries, Global Parts Direct and OE Source, the company focuses its efforts on utilizing its relationships with manufacturers in China, Korea and Japan to bring state-of-the-art automotive parts, accessories and products to automobile manufacturers and major parts distributors in the U.S. For more information on GAC and its products, visit www.generalautomotive.com.

GNAU News:

September 2 - General Automotive Announces Joint Venture Operating Terms

Acquisition Focused Automotive Company and Notable Ceramics Research Firm Join Forces in Automotive Fuel Cell and Sensor Technology Venture

General Automotive Company (OTCBB: GNAU), a North American provider of parts, accessories and advanced technology for the automotive industry, announces the operating agreement terms for their newly created joint venture named Advanced Composite Technology, LLC (ACT), per the Company’s recent 8-K filing denoting such in regard to its definitive agreement with SenCer, Inc.

General Automotive and SenCer recently formed the ACT joint venture to develop, commercialize and market SenCer’s groundbreaking UltraTemp™ ceramic composite materials for accelerating the development of energy-efficient, environmentally friendly fuel cell technologies.

The joint venture also intends to advance the development and commercialization of next-generation oxygen sensors, which represent a significant part of the Company’s current business, which generated total annual revenues of $15.3 million in 2007.

ACT’s groundbreaking technology solves the two most persistent problems in fuel cell design; cost and durability, by replacing expensive platinum conductors with co-fired proprietary ceramic conductive layers. The technology will also enable the design of more sophisticated oxygen sensors to help maximize fuel economy and minimize exhaust emissions for motor vehicles worldwide.

General Automotive President and CEO Joseph DeFrancisci commented, “Backed by extensive field test data supporting remarkable thermal properties and the bonding relationship with engineered oxide, conductive metals and ceramics coatings from SenCer’s breakthrough technology UltraTemp™; we believe this new joint venture will accelerate commercial development of potential industry-changing devices in the automotive sensor and fuel cell technology markets globally.”

Joint Venture Operating Terms with Commercial Viability Timeline

On July 22, 2008, General Automotive Company (GAC) and SenCer, Inc. entered into an Operating Agreement which sets forth the regulations, terms and conditions under which Advanced Composite Technology, LLC (ACT), the Joint Venture will be operated.

The Operating Agreement provides that GAC and SenCer shall each hold 50% membership interests in the Joint Venture. Initially, GAC shall contribute services and incur such costs and expenses as it shall deem necessary to determine the commercial viability of the Joint Venture’s business, of which services have an agreed-upon value of $200,000.

In the event GAC becomes satisfied that the business is commercially viable, GAC shall make additional capital contributions of up to $750,000 to fund the operations of the Joint Venture and SenCer shall contribute to the Joint Venture a license to use SenCer’s ceramic composite technology for any and all transportation applications, all pursuant to an exclusive license agreement by and between the Joint Venture and SenCer.

If commercial viability has not been achieved by January 15, 2009, the Joint Venture will be dissolved unless GAC elects to continue its existence. This early exit clause under General Automotive’s control, not only positions the Company for significantly greater shareholder value with very little risk, but also the short term time horizon that both joint venture partners expect to establish commercial viability by.

GAC shall be the sole managing member of the Joint Venture, responsible for the day-to-day operations as well as certain marketing activities for Advanced Composite Technology.

SenCer shall design and develop applications and prototype products for clients of the Joint Venture. The description of the Operating Agreement above is a summary and is qualified in its entirety by reference to the Operating Agreement as filed with the S.E.C.

ABOUT SENCER INC.

Established in 1996, SenCer Inc. is a technology research firm that has developed a ceramic composite material, UltraTemp™, with remarkable thermal properties and bonding capabilities. The new technology has applications in oxygen sensing (automotive and medical markets); oxygen generation (aluminum – inert anodes, gas generation, medical); and power generation (fuel cell technology). SenCer maintains a 20,000 square foot manufacturing facility in Penn Yan, NY.

FEATURED COMPANY

SPONGETECH DELIVERY SYSTEMS (OTCBB: SPNG)

Detailed Quote: http://www.otcpicks.com/quotes/SPNG.php

Company Profile: http://www.otcpicks.com/spongetech/spongetech.htm

SpongeTech Delivery Systems is a development stage company which designs, produces, markets and distributes cleaning products for vehicular use utilizing patented technology relating to sponges containing hydrophilic (liquid absorbing) foam polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, which is loaded with specially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.

SPNG News:

September 2 - SpongeTech® Delivery Systems, Inc. CEO Interviewed Live on Steve Crowley's American Scene Radio Show

SpongeTech's CEO Interview Aired Today on American Scene Radio Show

SpongeTech Delivery Systems, Inc. (OTCBB: SPNG) announced that its CEO and President, Michael Metter, will be interviewed today on Steve Crowley's American Scene Radio Show at 11:34 a.m. EDT. The interview can be heard live on BusinessTalkRadioNetwork® affiliate radio stations streamed on its website, www.businesstalkradio.net. You can find local radio stations by accessing the website, as well. Mr. Metter will be scheduled for future interviews on American Scene, where he will keep listeners updated on SpongeTech's products and developments.

FEATURED COMPANY

INDUSTRIAL BIOTECHNOLOGY CORPORATION (OTC: IBOT)

Detailed Quote: http://www.otcpicks.com/quotes/IBOT.php

Company Profile:
http://www.otcpicks.com/industrial-biotech/industrial-biotech-2.htm

Industrial Biotechnology Corporation, (IBC) provides products, services and technologies using renewable resources as an alternative to petroleum and traditional manufacturing methods. IBC production processes are eco-efficient and apply and adhere to sustainable practices and standards. IBC accomplishes this with the ALCHEMx Production Platforms™, which integrates technologies, sustainable manufacturing, and distribution with supply chain partners to meet customer needs and pricing requirements. IBC utilizes sugarcane based ethanol which is considered the leading cost efficient, energy balanced and environmentally sustainable feedstock source, when compared to petroleum and other alternative fuels.

IBOT News:

August 27 - Industrial Biotechnology Corporation Announces VP of Investor and Public Relations

Company Highlighted in BIOMASS Magazine

Industrial Biotechnology Corporation (OTC: IBOT) (IBC) announced the appointment of Craig McClure as VP of Investor and Public Relations. Mr. McClure has over 20 years in the investment services industry working as a licensed professional with companies such as Wachovia Securities, Aegon NV and LaSalle St. Securities.

“I am very pleased to join Industrial Biotechnology Corporation. Economic conditions, environmental concerns and the efficient use of the planet's food resources have placed sugar cane based ethanol at the forefront of efficient petroleum alternatives. Our current coverage in BIOMASS Magazine is indicative of the Industry interest we are receiving. Eco-efficient sugarcane ethanol used as both a petrochemical and fuel alternative makes the most sense economically and for the environment,“ said Craig McClure, IBC VP of Investor and Public Relations.

BIOMASS Magazine is produced by BBI Media, the world leader in biofuels/biomass industry publishing. They also publish Ethanol Producer Magazine and Biodiesel Magazine as well as offering an ever expanding line of online services. A copy of the article can be viewed here: BIOMASS Magazine September, 2008.

FEATURED COMPANY

CELEBDIRECT INCORPORATED (OTC: CELI)

Detailed Quote: http://www.otcpicks.com/quotes/CELI.php

Company Profile: http://www.otcpicks.com/celebdirect/celebdirect-2.htm

CelebDirect's primary business is that of a direct response celebrity incubator and has two divisions which are direct response marketing and Celebrity placement / franchise opportunities. CelebDirect brings to the market unique and innovative products via direct to market strategies such as infomercials, advertorials and other associated advertising vehicles to expeditiously, economically and broadly market products throughout North American as well as a global basis. CelebDirect has a number of consumer-oriented products it is evaluating and others it is currently bringing to market.

CELI News:

August 26 - CelebDirect Releases a New Corporate Flash Profile and Audio Interview with CEO Danny Alex Featured on Smallcapengine.com

CelebDirect (OTC: CELI) has announced that it is using Smallcapengine.com (www.Smallcapengine.com) to help with its marketing efforts via this new informative Flash Presentation/Profile/Audio Interview. The profile can be viewed in this link:

http://smallcapengine.com/company_profiles_view.aspx?id=143

STOCKS TO WATCH

NEUROCRINE BIOSCIENCES INCORPORATED (NASDAQ: NBIX)
"Up 8.21% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/NBIX.php

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. For more information, visit www.neurocrine.com.

NBIX News:

September 2 - Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis

Phase II Study Meets Primary Bone Mineral Density and Secondary Efficacy Endpoints

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced positive safety and efficacy results from its third Phase II clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis. The PETAL study enrolled 252 patients, with a confirmed diagnosis of endometriosis, into three treatment groups; elagolix 150 mg once daily, elagolix 75 mg twice daily, or depo-subQ provera 104(TM) (DMPA) for six months of treatment.

The primary endpoint for the PETAL study was the percent change from baseline in mean bone mineral density (BMD) at Month 6 measured via dual energy X-ray absorptiometry (DXA). Pursuant to discussion with the FDA, the pre-specified statistical analysis plan sought to demonstrate that at Month 6, the lower bound of the 95% confidence interval did not exceed a -2.2% change in BMD from baseline. In women randomized to elagolix 150 mg once daily, the mean percent change from baseline at Month 6 was -0.11% for the spine (lower bound -0.70%) and -0.47% for the femur (lower bound -0.96%). The mean percent change from baseline at Month 6 for the elagolix 75 mg twice daily dosing arm was -1.30% for the spine (lower bound -1.86%) and -0.99% for the femur (lower bound -1.46%).

"The PETAL study demonstrates that elagolix did not induce significant bone loss over a six month treatment of patients with endometriosis, while providing both rapid and significant pain reduction in endometriosis symptoms," said Chris O'Brien, MD, Chief Medical Officer at Neurocrine. "Additionally, this study confirms our decision to move forward with once daily dosing."

Secondary endpoints for the PETAL study were evaluated to assess the improvement of endometriosis symptoms following treatment with elagolix. Improvement in endometriosis symptoms was documented using several different scales for endometriosis pain. The following were assessed before, during and after the six months of treatment:

* Total Composite Pelvic Sign and Symptoms Score (CPSSS), a validated 0-15 scale that assesses five components of endometriosis pain severity, each on a 0-3 scale.

* Dysmenorrhea (pelvic pain during menstruation), a component of the CPSSS; 0-3 scale (0=absence of pain, 1=mild pain, 2=moderate pain, 3=severe pain).

* 98% of patients at baseline had moderate or severe dysmenorrhea.

* Non-menstrual pelvic pain (pelvic pain outside of menstruation), a component of the CPSSS; 0-3 scale (0=absence of pain, 1=mild pain, 2=moderate pain, 3=severe pain).

* 97% of patients at baseline had moderate or severe non-menstrual pelvic pain.

* Responder Rate, percentage of patients who had a one point or greater decrease in pain score.

* Visual Analog Scale (VAS) to assess pelvic pain levels using daily electronic diary.

Elagolix provided a clinically meaningful and statistically significant reduction in endometriosis pain from baseline as shown below. The magnitude of improvement is comparable to that demonstrated with the currently approved agents, leuprolide and DMPA.

"We have treated over 600 subjects with elagolix in our extensive endometriosis clinical program, and have consistently seen a robust reduction in endometriosis pain using multiple outcome measures. In our previous Phase II studies we have shown rapid onset of action and sustained efficacy over three months. This study extends those findings, demonstrating significant and sustained pain reduction for six months," said Dr. O'Brien. "There is much more data to come from this study once patients complete the six month follow-up and the study is unblinded at an individual patient level. At that time we will be able to make correlations between pain scores, BMD, pharmacokinetic values, and hormonal levels on an individual patient basis, and we look forward to also sharing those results, as soon as they are available."

Treatment with elagolix was also safe and generally well tolerated. Discontinuation from the clinical trial due to adverse events (AE) was more common among women randomized to DMPA (16%) than those receiving elagolix 150 mg once daily (5%) or 75 mg twice daily (7%). This increased discontinuation in women randomized to DMPA was primarily attributable to irregular vaginal bleeding. The overall rate of AE reporting was comparable across all groups. The most common AE was headache; this was reported 35 times by 19 women (23%) randomized to elagolix 150 mg once daily, 52 times by 22 women (26%) randomized to elagolix 75 mg twice daily, and 43 times by 12 (14%) women randomized to DMPA. There were two serious AEs that led to discontinuation from the trial, both in the DMPA group. The mean frequency of hot flashes was comparable in both the screening period and the treatment period, approximately 0.5 per day across all treatment groups, consistent with our prior Phase II studies.

"We couldn't be more pleased with the results of this study," said Kevin C. Gorman, President and Chief Executive Officer, Neurocrine Biosciences. "We began this program nine years ago with the hope of selectively modulating the GnRH system with an oral antagonist. This trial and our previous Phase II studies have now shown that this is possible. Elagolix is a first in class drug for endometriosis sufferers who desperately need a safe and effective therapy. This is apparent from the 8,000 inquiries to the call center for just this one study. Additionally, to date we had more than 6,000 inquiries regarding the ongoing Lilac PETAL study which is now fully enrolled and on track to report results in 2009."

"These study results are very encouraging," said Shayne M. Plosker, MD, Associate Professor and Division Director, of USF IVF and Reproductive Endocrinology at the University of South Florida College of Medicine in Tampa. "Elagolix has the potential to be an ideal advanced medical therapy for endometriosis-associated pelvic pain and dysmenorrhea. Intermediate suppression of estradiol by a well-tolerated drug appears attainable affording endometriosis symptom reduction without bone loss."

MONARC CORPORATION (OTC: MONA)
"Up 50.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MONA.php

Monarc Corporation was formed in 2000. The company acquired multiple subprime short term lending companies for the B2C marketplace doing business under the brand name "Cash Now" in 2003. The company also had an array of other financial products such as IFGX and Cash Next under development for the B2B marketplace; such as invoice discounting and factoring. In 2005 the company suffered a setback with 4 consecutive strikes of hurricanes of 2005 while domiciled in Florida. Unable to operate on a day to day basis without interruptions, the company was delisted from being am SEC reporting issuer soon after and consequently its stock was re-ranked as an unsolicited stock and 2006 was a reconstructing year. The company used the time out to raise capital with the issuance of preferred convertible shares. Soon after, in January 2007, it resumed operations. With the sweeping changes in the subprime industry and with most of the States and Provinces restricting this product use the company looked at different industries. In 2007, it launched a Check 21 product and a Forex division and looked towards China as a growth market. In late 2007 MONA sold these aforementioned operating assets to a China-based company and the proceeds of that sale were distributed to its shareholders. In early 2008, MONA looked for another growth industry and decided to enter beverage control. The company acquired 3 start-up entities in the hospitality control industry. In December 2007, the controlling interest of Monarc was purchased by Brookcor Holdings, on an all cash and stock basis. Those businesses were spun out several months later and the paid stock returned to the treasury. MONA identified a China-based mass distribution company and completed a reverse merger with them through their Belize holding company Fulushu Limited in June 2008. The company continues operating these entities as it nears completion of the development of its B2B product line. The company is also currently in a process of filing certain documents to remove the warning sign from the Pink Sheets quotation system and to again become a solicited company, with future plans on becoming an SEC reporting issuer. MONA is also taking measures to raise the pink sheets ranking from "Yield limited information" to a "pink check mark status."

MONA News:

September 2 - MonArc Corporation Announces Change Of Corporate Direction

MonArc Corporation (OTC: MONA) (www.monacorporation.com) announced that it is in the process of liquidating certain assets, and operating subsidiaries to 2 or possibly 3 different buyers.

Once the aforementioned sale of assets transaction is completed MONA would itself be bought out on all cash basis by a Chinese based Direct Marketing Company MCD. MCD intends to fully complete the Corporate Compliance to achieve a solicited issuer status. MCD is also desirous to add its 7,000 plus current shareholder base to MONA.

In the unlikely event for whatever reason this Corporate Compliance threshold cannot be met then the issuer intends to amend its corporate resolution to become a USA based Special Purpose Acquisition Company (SPAC).

One of the unique characteristics that MONA can offer is a constant dividend to its shareholders in all of these various China based companies.

The issuer has filed a comprehensive Corporate Update Filing on Pink Sheets, which can be viewed by visiting this link directly:

http://www.pinksheets.com/otciq/ajax/showFinancialReportById.pdf?id=16945

MONA management believes that it is an excellent candidate to be a SPAC Company. With these aforementioned asset sales and spin outs it would represent 3 separate dividend payouts in 2008 for the issuer.

EXPO HOLDINGS INCORPORATED (OTC: EXPH)
"Up 9.68% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/EXPH.php

Expo Holdings operates in North Wilkesboro, NC. D&D Displays is a wholly owned subsidiary of Expo Holdings, which specializes in custom cabinetry and high end store fixtures for retail vendors such as Newell-Rubbermaid, Inc., Bosch Tool Corporation, Kronotex, USA, and S&K Men's Wear. D&D Displays has been in operation since 2000 and joined Expo Holdings in 2006.

EXPH News:

September 3 - Expo Holdings, Inc. to Retire Regulation D 504 Offering

Expo Holdings, Inc. (OTC: EXPH), a holding Company, which wholly owns D&D Displays, Inc., is pleased to announce to shareholders that it will close its Regulation D 504 Offering.

James D. Brown, Expo Holdings CEO, stated, "Closing the 504 brings to an end our recent use of equity in financing operations. With our new increased pool of credit we can now tackle the majority of our upfront costs associated with our increasing contract demands. I'm looking forward to releasing quite a bit of new information over the next few weeks as well as outlining our business plan to shareholders and potential investors."

Shareholders and potential investors who have not yet viewed the company's videos are encouraged to do so at http://www.youtube.com/user/EXPOHOLDINGS. Part I introduces individuals to D&D Displays products and management. Part II takes individuals on a tour of D&D Displays manufacturing and distribution center.

BIOSOLAR INCORPORATED (OTC: BSRC)
"Up 11.11% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/BSRC.php

BioSolar, Inc. engages in the research and development of bioplastic materials from renewable plant sources for use in photovoltaic solar cells. The company develops bio-based plastics components that meet the thermal and durability requirements of solar cell manufacturing processes for conventional crystalline cell designs, as well as thin film photovoltaic devices in an effort to capitalize on cost advantages to current petroleum based solar cell components. Its bioplastic materials can be also used directly in conventional manufacturing systems, such as injection molding and thin-film roll-to-roll, to create superstrate layer, substrate layer, and backsheet, as well as module and panel components. The company was founded in April 2006. It was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. is headquartered in Santa Clarita, California.

BSRC News:

September 3 - BioSolar Inc. Reiterated 'Speculative Buy,' Target Price $1.37 by Beacon Equity Research

BioSolar Inc. (OTCBB: BSRC) received a reiterated “Speculative Buy” with a price target of $1.37 by Beacon Analyst, Victor Sula, Ph.D.

The full report is available at www.beaconequity.com/adpages/BSRC.

In the report, the analyst writes, “The Company is transitioning to full-scale production of its BioBacksheet™ in a state-of-the-art manufacturing facility operated by its contract manufacturing partner, Rowland Technologies Inc. and expects to report meaningful revenues by year-end 2008 as it commences full-scale production of its bio-based material.”

Other companies in the solar/technology industry include: Solarfun Power Holdings Co. Ltd. (Nasdaq: SOLF), Ascent Solar Technologies (Nasdaq: ASTI), Evergreen Solar (Nasdaq: ESLR) and Suntech Power Holdings (NYSE: STP).

COMSTOCK HOMEBUILDING COMPANIES (NASDAQ: CHCI)
"Up 24.38% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CHCI.php

Comstock Homebuilding Companies, Inc. operates as a real estate developer in the United States. The company primarily develops and builds single-family homes, townhouses, mid-rise condominiums, high-rise multi-family buildings, and mixed-use developments in suburban communities and high density urban infill areas. It serves first-time, early move-up, secondary move-up, and empty nester move-down buyers primarily located in Washington, D.C.; Raleigh, North Carolina; Atlanta; and Georgia markets. The company also engages in the development, redevelopment, and construction of residential mid-rise and high-rise condominium complexes. As of December 31, 2007, Comstock Homebuilding built and delivered approximately 5,000 homes. The company was founded in 1985. It was formerly known as Comstock Companies, Inc. and changed its name to Comstock Homebuilding Companies, Inc. in 2004. The company is headquartered in Reston, Virginia.

CHCI News:

September 2 - Comstock Homebuilding Companies, Inc. Eliminates $32.7 Million of Debt Through Friendly Foreclosure Agreement With BB&T

Comstock Homebuilding Companies, Inc. (Nasdaq: CHCI) and certain of its subsidiaries (collectively "Comstock" or the "Company") announced that on Friday, August 29, 2008 it had entered into a foreclosure agreement ("Agreement") with Branch Banking and Trust Company ("BB&T") with respect to approximately $32.7 million of the Company's $144.0 million of secured debt. Under the terms of the Agreement, the Company agreed to cooperate with BB&T with respect to its foreclosure on certain of the Company's real estate assets and BB&T agreed to provide the Company a full release from its obligations with no deficiency liability post-foreclosure. The foreclosure agreement covers properties in Virginia and Atlanta. Comstock will retain pre-sold lots in Atlanta which are not included in the foreclosure.

"As previously announced we are working to restructure a significant portion of our debt to ensure our ability to survive what has turned out to be the worst cyclical market downturn in a generation. We are pleased with the results of our negotiation with BB&T and consider this an important first step in our plan to reposition Comstock to meet current market challenges," said Christopher Clemente, Comstock's Chairman and Chief Executive Officer. "We continue to focus on similar negotiations with certain other lenders and remain optimistic regarding the outcome of those negotiations."

It is expected that on September 2, 2008 BB&T will complete the foreclosure process on select lots at Maristone, James Road, Wyngate and Glen Ivy, all in the Atlanta, Georgia market and that on or before September 30, 2008, BB&T will complete the foreclose process on the collateral securing the Company's debt at two projects in Virginia, Barrington Park and Woodlands of Round Hill. The Company announced that in anticipation of this agreement it had recorded impairment charges related to the BB&T collateral in the quarter ending June 30, 2008 and as a result the Company does not anticipate any material future write-offs as a result of the Agreement or the foreclosures.

PINNACLE ENERGY CORPORATION (OTCBB: PENC)
"Up 3.22% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PENC.php

Formerly named Gas Salvage Corp., Pinnacle Energy has recently completed a name change and a three-for-one forward stock split. The company now trades under the OTC symbol "PENC." All of the above-listed changes were made effective with FINRA on August 14, 2008. More information about these changes may be found in a FORM 8-K filed with the Securities and Exchange Commission on August 8, 2008. Pinnacle Energy Corp. is an independent oil and gas producer focused on acquiring and developing mature oil & gas producing assets. Pinnacle Energy Corp. is headquartered at 333 River Front Ave., Suite 153, Calgary, Alberta, T2G 5R1, Canada and can be contacted at (866) 822-0325.

PENC News:

August 29 - Pinnacle Energy Corp. Acquires Six Oil & Gas Producing Wells

Pinnacle Energy Corp. (OTCBB: PENC), an independent oil and gas producer, announced that it has acquired working interests in six wells located in Pawnee County, Oklahoma, USA. Five of the six wells produce high gravity light sweet crude oil, and the sixth is a saltwater disposal well.

As of August 27, 2008, the five oil wells are producing 20 barrels of oil per day, and 30 MCF (30,000 cubic feet) of gas per day, net to the Company’s interest. Acquisition cost for the wells was $1,000,000 USD, and Pinnacle Energy has a 25.5% working interest (20.4% net revenue interest) in two wells, a 20% working interest (16% net revenue interest) in three wells, and a 17% working interest (13.6% net revenue interest) in the remaining well.

“Current production and reserve reports suggest that the Glencoe field in Pawnee County, Oklahoma has excellent long-term development potential,” said Pinnacle Energy CEO Nolan Weir. “We look forward to developing the field to its fullest potential in the very near future.”

JAMBA INCORPORATED (NASDAQ: JMBA)
"Up 6.39% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/JMBA.php

Jamba, Inc., through its subsidiary, Jamba Juice Company, owns and franchises Jamba Juice stores. The company operates as a retailer of blended-to-order fruit smoothies, squeezed-to-order juices, blended beverages, and snacks in the United States. As of January 1, 2008, it operated 707 stores comprising 501 company-owned stores and 206 franchisee-owned stores. The company was founded in 1990 and is headquartered in Emeryville, California.

JMBA News:

August 28 - Nestle USA and Jamba Announce Early Success with Ready-to-Drink Beverages

Jamba® Ready-to-Drink Exceeds Expectations in Eight Western States

Nestlé USA, part of Nestlé, S.A., the world’s largest food and beverage company, and Jamba Inc. (Nasdaq: JMBA), the leading blender of fruit and other naturally healthy ingredients, announced the early success of the Jamba® ready-to-drink beverages in eight Western U.S. states. Since its launch in May, Jamba® ready-to-drink beverages have captured a significant share of the premium juice segment, exceeding initial expectations.

Jamba Smoothies and Jamba Juicies are available in hundreds of locations, including major grocery retailers and convenience stores in California, Oregon, Utah, Nevada, Arizona, Idaho, Washington and Colorado. Retail accounts include Safeway, Albertsons, Ralph’s, 7-Eleven, Raley’s, and Walgreens, among others.

“We are thrilled at the success of the Jamba ready-to-drink beverages, which have surpassed our initial sales expectations,” said Steve Presley, vice president, general manager premium ready-to-drink, Nestlé Beverage Division.

Nestlé is supporting the launch of Jamba RTD with significant product sampling, on-line activity, consumer outreach public relations and in-store promotions. In addition, television ads for Jamba RTD began airing in June in both San Francisco and Portland.

“The initial success of the ready-to-drink product demonstrates the power and strength of the Jamba brand outside the four walls of our retail stores, in California as well as less mature Jamba markets such as Portland,” said Paul Coletta, chief marketing and brand officer at Jamba. “In just a few months, Jamba ready-to-drink has exceeded our expectations for initial sales. Based on this, we see tremendous opportunity for the product as we continue to execute upon our plan to make Jamba Juice available to our customers 24/7.”

The 2008 Jamba ready-to-drink product line includes six SKUs: three Jamba Smoothies, named Strawberries Wild w/Energy Boost, Orange Dream Machine w/Immunity, Banana Berry w/Heart Healthy Boost; and, three Jamba Juicies named Orange Strawberry Banana w/Protein Boost, Mango Orange Peach w/Fiber Boost, Very Berry w/Calcium Boost.

ABOUT NESTLÉ USA

Named one of “America’s Most Admired Food Companies” in Fortune magazine for the eleventh consecutive year, Nestlé USA provides quality brands and products that bring flavor to life every day. From nutritious meals with LEAN CUISINE® to baking traditions with NESTLÉ® TOLL HOUSE®, Nestlé USA makes delicious, convenient, and nutritious food and beverage products that enrich the very experience of life itself. That’s what “Nestlé. Good Food, Good Life” is all about. Nestlé USA, with 2007 sales of $8.25 billion, is part of Nestlé S.A. in Vevey, Switzerland — the world’s largest food company — with sales of $90 billion.

UNIVERSAL TRAVEL GROUP INCORPORATED (OTCBB: UTVG)
"Up 7.46% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/UTVG.php

Universal Travel Group, a fast growing travel services provider in China, is engaged in providing reservation, booking, and domestic and international travel and tourism services throughout China via the internet and through customer representatives. Under the theme "Wings towards a more colorful life" the company's core services include tour packaging for customers, booking services for air tickets and hotels as well as air cargo transportation. In 2007, Universal Travel Group completed the acquisitions of Speedy Dragon, specializing in air cargo transportation; Xi'an Golden Net, specializing in travel packaged tours; Shanghai LanBao, specializing in hotel reservation and Foshan Overseas International, a China-based company that handles domestic and international travel inquiries. Universal Travel's goal is to become China's leading travel services provider in all fields of the tourism industry including the aviation, cargo, hotel booking and tour packaging segments. For more information, visit http://us.cnutg.com.

UTVG News:

September 3 - Universal Travel Group Closes $7.11 Million PIPE Financing

Group of Seasoned Institutional Investors Acquire an Additional 5MM Shares of Stock from a Non-Management Shareholder

Universal Travel Group Inc. (OTCBB: UTVG) (“Universal Travel Group” or the “Company”), a growing travel services provider in the People's Republic of China specializing in online and customer representative services to the travel service industry offering packaged tours, air ticketing, hotel reservation and air cargo agency services, announced that it has successfully closed a private placement financing with established institutional investors with extensive experience investing in the People's Republic of China including Chinamerica Fund LP, Access America Fund, Pope Investments II LLC, Heller Capital, and Investment Hunter, LLC (collectively, ''Investors'').

In the PIPE transaction, the Company issued and sold to Investors approximately 4.8 million shares of the Company's common stock at a purchase price of $1.55 per share, for an approximate aggregate purchase price of $7.11 million, which closed on August 29, 2008

Proceeds from the private placement will be used for general corporate development, specifically projects relating to online integration.

“We are determined to capture the opportunities presented by the tourism and business travel markets in China and will use the proceeds to fuel our growth initiatives,” said Ms. Jiangping Jiang, CEO of Universal Travel Group. “We are also pleased that such respectable institutional investors have recognized us and placed their confidence in our long-term growth plans.”

“We are very excited about the growth prospects of Universal Travel Group,” stated Christopher Efird of Access America. “Given the value of other public travel services providers, we believe that Universal Travel Group is one of the Chinese companies in the space with the most potential to build on its current platform to provide premium services to consumers and build significant franchise value for its shareholders.”

In addition to the PIPE transaction, on August 14, 2008, Access America Fund, Chinamerica Fund LP and Pope Investments II LLC purchased 5 million shares of UTVG from a non-management shareholder of the Company. The Stock Purchase Agreement included a mutual general release of all future claims from China Finance, Inc. and affiliates. Information about the private sale of 5 million shares is available in the Company's current report on Form 8-K which was filed with the Securities and Exchange Commission on August 1, 2008.

“While we did not receive any proceeds from the 5 million share purchase transaction, we were pleased to see that the shares are now held by long term institutional investors that have track records of success in growth investments,” said Ms. Jiang.

“After several months of due diligence, including in-depth analysis of the Chinese travel space, we believed this dynamic company was significantly undervalued. We are hopeful that when the investment community at large recognizes that a group of sophisticated institutional investors with successful track records investing in, and supporting Chinese companies have accumulated a meaningful position in UTVG that, over time, shareholder value will rise to intrinsic levels. In addition to acquiring this large block of stock from a single non-management shareholder, we had enough confidence in the Company to place the PIPE financing at a premium to the retail price per share in the open market, something rarely done in our space,” said Beau Johnson of Chinamerica Fund.

The securities issued in the PIPE have not been registered under the Securities Act of 1933, as amended, and may not be sold by the investor in the United States, except pursuant to an effective registration statement or an applicable exemption from the registration requirements. The Company has agreed to file a registration statement covering the re-sale of the securities by the investor.